图片名称

Shandong Lukhai Haier Biotechnology Co., Ltd. held the first session of the board of directors

Release time:

2022-06-28


On the morning of July 21, the first board of directors of Shandong Lukhai Haier Biotechnology Co., Ltd. was held in the company conference room, marking the official start of the production and operation of the joint venture company.
 
The meeting reviewed and approved the proposal of electing Peng Xin, general manager of Lukang Pharmaceutical Co., Ltd. as the chairman of the joint venture company; and appointing Li Jian, general manager of Shandong Lukang Biological Pesticide Co., Ltd., as the general manager of the joint venture company and Maria Naira as the executive deputy general manager; The general policy of the joint venture company was determined: the three products of HeberNem, FT and Acuabio4 were industrialized in the joint venture company, and registered and sold within the scope of authorization in China and Southeast Asia to realize the commercialization of the products and the continued profitability of the company; The annual business plan and budget and investment plan; 11 proposals for the company's first phase of the human resources plan and compensation plan.
 
Shandong Lukhai Haier Biotechnology Co., Ltd. was successfully registered on March 28, 2016. It was jointly funded by Shandong Lukang Biological Pesticide Co., Ltd. and Cuban Haiboer. The registered capital of the company is US$9.9 million. Shandong Lukang Biological Pesticide Co., Ltd. accounted for 60%, and HEBER BIOTEC S.A Company accounted for 40%. The company occupies more than 58,000 square meters. There are 30 professional and technical personnel in Cuba and China, and more than 180 employees. The company's existing bio-nematic nematode products Hebernem, aquatic product immunization drug Acuabio4, new FOS biocatalytic enzyme FT and other industry leading products. Among them, Hebernem is a bio-nematic nematode product with high efficacy against root-knot nematodes in the international arena.
 
Shandong Lukhai Haier Biotechnology Co., Ltd. will carry out work in accordance with the various proposals approved by the board of directors to ensure the smooth completion of the plan.